Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Carcinoma 5Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Mouth Neoplasms 3Colorectal Neoplasms 3Adenocarcinoma 3Skin Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Laryngeal Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Vaccinia 1Triple Negative Breast Neoplasms 1Solid Tumors 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Rectal Neoplasms 1Prostatic Neoplasms 1

Interventions

Cisplatin 13Magnetic Resonance Spectroscopy 9Specimen Handling 8Radiotherapy 7Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Radiotherapy, Intensity-Modulated 4Radiation 4Biopsy 4Surveys and Questionnaires 3Nivolumab 3Carboplatin 3pembrolizumab 2durvalumab 2Observation 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Docetaxel 2Disulfides 2Chemoradiotherapy 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2niraparib 1merphos 1ipatasertib 1dostarlimab 1cemiplimab 1cabozantinib 1balstilimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × cemiplimab × 30 days × Clear all
NCT07195734 2026-05-19

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
180 enrolled
Head & Neck

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡